In the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) trial, the baseline level of high-sensitivity C-reactive protein (hs-CRP) predicted which patients were at the greatest risk for cardiovascular events.

Authors

• Person: Not available Organization: National Lipid Association
  EBM Tools for Practice: Best Biomarkers for Inflammation

Sources

• EBM Tools for Practice: Best Biomarkers for Inflammation www.lipid.org National Lipid Association via serper

Referenced by nodes (2)

• high-sensitivity C-reactive protein concept
• cardiovascular events concept